Cem Tanrıöver

476 total citations
24 papers, 292 citations indexed

About

Cem Tanrıöver is a scholar working on Nephrology, Infectious Diseases and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cem Tanrıöver has authored 24 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Infectious Diseases and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cem Tanrıöver's work include COVID-19 Clinical Research Studies (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Dialysis and Renal Disease Management (5 papers). Cem Tanrıöver is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Dialysis and Renal Disease Management (5 papers). Cem Tanrıöver collaborates with scholars based in Türkiye, United States and Italy. Cem Tanrıöver's co-authors include Mehmet Kanbay, Sidar Çöpür, Katherine R. Tuttle, David Z.I. Cherney, Mehmet Gönen, Carmine Zoccali, Carlo Basile, Adrian Covic, Francesca Mallamaci and Önder Ergönül and has published in prestigious journals such as Clinical Microbiology and Infection, Pharmaceutics and European Journal of Clinical Investigation.

In The Last Decade

Cem Tanrıöver

23 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cem Tanrıöver Türkiye	11	70	68	52	44	40	24	292
Nicholas Cole United Kingdom	11	64 0.9×	37 0.5×	36 0.7×	51 1.2×	27 0.7×	19	276
Hasan Kayabaşı Türkiye	12	107 1.5×	32 0.5×	58 1.1×	62 1.4×	36 0.9×	35	340
Cleto Álvarez-Aguilar Mexico	10	87 1.2×	60 0.9×	31 0.6×	33 0.8×	53 1.3×	18	337
Anna Shin South Korea	10	77 1.1×	35 0.5×	34 0.7×	52 1.2×	27 0.7×	25	314
Gurpreet Johal United States	10	23 0.3×	65 1.0×	32 0.6×	26 0.6×	30 0.8×	30	274
Mihaela Adela Iancu Romania	12	36 0.5×	25 0.4×	37 0.7×	64 1.5×	37 0.9×	51	303
Xiaoguang Wu China	12	40 0.6×	52 0.8×	72 1.4×	71 1.6×	26 0.7×	26	358
Peng‐Fei Xia China	11	15 0.2×	60 0.9×	70 1.3×	36 0.8×	30 0.8×	20	332
Alberto Caldas Afonso Portugal	13	135 1.9×	56 0.8×	67 1.3×	40 0.9×	118 3.0×	40	497
Sneha Annie Sebastian United States	11	24 0.3×	60 0.9×	34 0.7×	58 1.3×	50 1.3×	47	364

Countries citing papers authored by Cem Tanrıöver

Since Specialization

Citations

This map shows the geographic impact of Cem Tanrıöver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Tanrıöver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Tanrıöver more than expected).

Fields of papers citing papers by Cem Tanrıöver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cem Tanrıöver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Tanrıöver. The network helps show where Cem Tanrıöver may publish in the future.

Co-authorship network of co-authors of Cem Tanrıöver

This figure shows the co-authorship network connecting the top 25 collaborators of Cem Tanrıöver. A scholar is included among the top collaborators of Cem Tanrıöver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cem Tanrıöver. Cem Tanrıöver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanrıöver, Cem, et al.. (2024). Angiopoietin as a Novel Prognostic Marker in Kidney Disease. Blood Purification. 53(6). 425–435.

Tanrıöver, Cem, et al.. (2023). Early aging and premature vascular aging in chronic kidney disease. Clinical Kidney Journal. 16(11). 1751–1765. 25 indexed citations

Tanrıöver, Cem, et al.. (2023). A new immune disease: systemic hypertension. Clinical Kidney Journal. 16(9). 1403–1419. 4 indexed citations

Kanbay, Mehmet, et al.. (2023). Future treatments in hypertension: Can we meet the unmet needs of patients?. European Journal of Internal Medicine. 115. 18–28. 8 indexed citations

Kanbay, Mehmet, Sidar Çöpür, Cem Tanrıöver, et al.. (2023). A novel risk factor for malignancy: Albuminuria. European Journal of Internal Medicine. 118. 22–31. 3 indexed citations

Tanrıöver, Cem, Sidar Çöpür, Abduzhappar Gaipov, et al.. (2023). Metabolically healthy obesity: Misleading phrase or healthy phenotype?. European Journal of Internal Medicine. 111. 5–20. 29 indexed citations

Kanbay, Mehmet, et al.. (2023). Social isolation and loneliness: Undervalued risk factors for disease states and mortality. European Journal of Clinical Investigation. 53(10). e14032–e14032. 17 indexed citations

Tanrıöver, Cem, et al.. (2023). Tirzepatide and potential use for metabolically healthy obesity. European Journal of Internal Medicine. 113. 1–5. 12 indexed citations

Keske, Şiran, et al.. (2023). Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis. Infection. 51(6). 1619–1628. 4 indexed citations

10.

Kanbay, Mehmet, Carina Ureche, Sidar Çöpür, et al.. (2023). Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease. Sleep And Breathing. 27(5). 1667–1675. 6 indexed citations

11.

Tanrıöver, Cem, et al.. (2023). A potential approach toward the management of sepsis: The extracorporeal cytokine hemadsorption therapy. Seminars in Dialysis. 37(2). 117–121. 1 indexed citations

12.

Tanrıöver, Cem, et al.. (2023). Dialysis after kidney transplant failure: how to deal with this daunting task?. Journal of Nephrology. 36(7). 1777–1787. 4 indexed citations

13.

Kanbay, Mehmet, et al.. (2022). Kidney transplantation: is it a solution to endothelial dysfunction?. International Urology and Nephrology. 55(5). 1183–1191. 2 indexed citations

14.

Tanrıöver, Cem, et al.. (2022). On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease. Journal of Nephrology. 35(9). 2191–2204. 18 indexed citations

15.

Tanrıöver, Cem, et al.. (2022). Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon. Sleep And Breathing. 27(1). 77–89. 17 indexed citations

16.

Tanrıöver, Cem, et al.. (2022). A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases. 41(5). 761–769. 8 indexed citations

17.

Kanbay, Mehmet, Carina Ureche, Cem Tanrıöver, et al.. (2021). Effect of sodium–glucose cotransporter 2 inhibitors on hemoglobin and hematocrit levels in type 2 diabetes: a systematic review and meta-analysis. International Urology and Nephrology. 54(4). 827–841. 39 indexed citations

18.

Tanrıöver, Cem, Asiye Kanbay, Adrian Covic, et al.. (2021). Immunogenicity of SARS-CoV-2 mRNA vaccine in dialysis and kidney transplant patients: A systematic review. Tuberkuloz ve Toraks. 69(4). 547–560. 8 indexed citations

19.

Kanbay, Mehmet, Asiye Kanbay, Cem Tanrıöver, et al.. (2021). Acute kidney injury in hospitalized COVID-19 patients. International Urology and Nephrology. 54(5). 1097–1104. 9 indexed citations

20.

Ergönül, Önder, Cem Tanrıöver, Henning Tiemeier, et al.. (2020). National case fatality rates of the COVID-19 pandemic. Clinical Microbiology and Infection. 27(1). 118–124. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact